NCT02153320View on ClinicalTrials.gov

Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

September 5, 2005

Primary Completion Date

October 28, 2005

Study Completion Date

October 28, 2005

Conditions
Hepatitis B
Interventions
PROCEDURE

Blood Sampling

Single blood sample taken from subjects who had participated in the study 287615 (NCT00508833).

Trial Locations (2)

1200

GSK Investigational Site, Brussels

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY